About Thyme Care
Thyme Care is a private company based in Nashville, Tennessee. It has reported $214,317,916 raised in four offerings on Form D since November 2021. Its chief executive is Robin Shah.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 4, 2025 | Sep 25, 2025 | $97,047,918of $100.0M target | 14 | $6.9M | EquityRule 506(b) | Form D ↗ |
| Jul 11, 2024 | Jul 23, 2024 | $54,499,996fully sold | 13 | $4.1M | EquityRule 506(b) | Form D ↗ |
| Jun 23, 2023 | Aug 22, 2023 | $49,000,000of $60.0M target | 13 | $3.7M | EquityRule 506(b) | Form D ↗ |
| May 14, 2021 | Nov 30, 2021 | $13,770,002of $18.0M target | 10 | $1.3M | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $214,317,916 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Thyme Care's Form D filed Sep 25, 2025.
DW
David Whelan
Director
BD
Bradford Diephuis
Executive officer
RG
Robert Green
Executive officer and director
BB
Brian Belsky
Director
MM
Michael Markowicz
Executive officer
VG
Vivek Garipalli
Director
Vineeta Agarwala
Director
Also a director at Arda Therapeutics, BigHat Biosciences and Rezo Therapeutics.
EC
Elizabeth Canis
Director
RS
Robin Shah
Chief Executive Officer and director
VP
Vijay Patel
Director
BF
Brenton Fargnoli
Director
PS
Puneet Singh
Director
JW
Jesse Waldron
Executive officer